Novel nanolattices comprising cross-linked or chelated polymers having a desired polydispersity index suitable for delivery of pharmaceutical agents and complexes comprising same are described. Methods of making the nanolattices and use of the nanolattices to deliver pharmaceutical agents for use in a range of diagnostic, prophylactic, therapeutic, nutritional and/or research applications are also described.
-
Page/Page column 72
(2010/11/29)
More Articles about upstream products of 60659-91-8